Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
THE RELATION BETWEEN THE TYPE SPECIFIC CARBOHYDRATES OF PNEUMOCOCCI AND THE BLOOD GROUP SPECIFIC SUBSTANCE A.

The Journal of experimental medicine

Witebsky E, Neter E, Sobotka H.
PMID: 19870386
J Exp Med. 1935 Apr 30;61(5):703-15. doi: 10.1084/jem.61.5.703.

1. A relationship between the soluble specific substances of pneumococci and the blood group substance A of man can be demonstrated by the inhibition of sheep cell hemolysis by a group specific A-antiserum. However, there are quantitative differences between...

Cite
Witebsky E, Neter E, Sobotka H. THE RELATION BETWEEN THE TYPE SPECIFIC CARBOHYDRATES OF PNEUMOCOCCI AND THE BLOOD GROUP SPECIFIC SUBSTANCE A. J Exp Med. 1935;61(5):703-15doi: 10.1084/jem.61.5.703.
Witebsky, E., Neter, E., & Sobotka, H. (1935). THE RELATION BETWEEN THE TYPE SPECIFIC CARBOHYDRATES OF PNEUMOCOCCI AND THE BLOOD GROUP SPECIFIC SUBSTANCE A. The Journal of experimental medicine, 61(5), 703-15. https://doi.org/10.1084/jem.61.5.703
Witebsky, E, et al. "THE RELATION BETWEEN THE TYPE SPECIFIC CARBOHYDRATES OF PNEUMOCOCCI AND THE BLOOD GROUP SPECIFIC SUBSTANCE A." The Journal of experimental medicine vol. 61,5 (1935): 703-15. doi: https://doi.org/10.1084/jem.61.5.703
Witebsky E, Neter E, Sobotka H. THE RELATION BETWEEN THE TYPE SPECIFIC CARBOHYDRATES OF PNEUMOCOCCI AND THE BLOOD GROUP SPECIFIC SUBSTANCE A. J Exp Med. 1935 Apr 30;61(5):703-15. doi: 10.1084/jem.61.5.703. PMID: 19870386; PMCID: PMC2133242.
Copy Download .nbib Format: NLM
THE ISOLATION OF AN O SPECIFIC SUBSTANCE FROM GASTRIC JUICE OF SECRETORS AND CARBOHYDRATE-LIKE SUBSTANCES FROM GASTRIC JUICE OF NON-SECRETORS.

The Journal of experimental medicine

Witebsky E, Klendshoj NC.
PMID: 19871103
J Exp Med. 1941 Apr 30;73(5):655-67. doi: 10.1084/jem.73.5.655.

1. The isolation of a group specific O substance from the gastric juice of human beings belonging to group O is described. Absorbed normal beef serum constitutes the anti-O reagent. 2. The O specific substance inhibits the agglutination of...

Cite
Witebsky E, Klendshoj NC. THE ISOLATION OF AN O SPECIFIC SUBSTANCE FROM GASTRIC JUICE OF SECRETORS AND CARBOHYDRATE-LIKE SUBSTANCES FROM GASTRIC JUICE OF NON-SECRETORS. J Exp Med. 1941;73(5):655-67doi: 10.1084/jem.73.5.655.
Witebsky, E., & Klendshoj, N. C. (1941). THE ISOLATION OF AN O SPECIFIC SUBSTANCE FROM GASTRIC JUICE OF SECRETORS AND CARBOHYDRATE-LIKE SUBSTANCES FROM GASTRIC JUICE OF NON-SECRETORS. The Journal of experimental medicine, 73(5), 655-67. https://doi.org/10.1084/jem.73.5.655
Witebsky, E, and Klendshoj, N C. "THE ISOLATION OF AN O SPECIFIC SUBSTANCE FROM GASTRIC JUICE OF SECRETORS AND CARBOHYDRATE-LIKE SUBSTANCES FROM GASTRIC JUICE OF NON-SECRETORS." The Journal of experimental medicine vol. 73,5 (1941): 655-67. doi: https://doi.org/10.1084/jem.73.5.655
Witebsky E, Klendshoj NC. THE ISOLATION OF AN O SPECIFIC SUBSTANCE FROM GASTRIC JUICE OF SECRETORS AND CARBOHYDRATE-LIKE SUBSTANCES FROM GASTRIC JUICE OF NON-SECRETORS. J Exp Med. 1941 Apr 30;73(5):655-67. doi: 10.1084/jem.73.5.655. PMID: 19871103; PMCID: PMC2135150.
Copy Download .nbib Format: NLM
BLOOD GROUP SPECIFIC SUBSTANCES AND BLOOD TRANSFUSIONS.

Science (New York, N.Y.)

Witebsky E, Klendshoj NC.
PMID: 17792883
Science. 1941 Sep 12;94(2437):256-7. doi: 10.1126/science.94.2437.256.

No abstract available.

Cite
Witebsky E, Klendshoj NC. BLOOD GROUP SPECIFIC SUBSTANCES AND BLOOD TRANSFUSIONS. Science. 1941;94(2437):256-7doi: 10.1126/science.94.2437.256.
Witebsky, E., & Klendshoj, N. C. (1941). BLOOD GROUP SPECIFIC SUBSTANCES AND BLOOD TRANSFUSIONS. Science (New York, N.Y.), 94(2437), 256-7. https://doi.org/10.1126/science.94.2437.256
Witebsky, E, and Klendshoj, N C. "BLOOD GROUP SPECIFIC SUBSTANCES AND BLOOD TRANSFUSIONS." Science (New York, N.Y.) vol. 94,2437 (1941): 256-7. doi: https://doi.org/10.1126/science.94.2437.256
Witebsky E, Klendshoj NC. BLOOD GROUP SPECIFIC SUBSTANCES AND BLOOD TRANSFUSIONS. Science. 1941 Sep 12;94(2437):256-7. doi: 10.1126/science.94.2437.256. PMID: 17792883.
Copy Download .nbib Format: NLM
INVESTIGATIONS ON THE OCCURRENCE OF Rh SUBSTANCES IN AMNIOTIC FLUID.

The Journal of experimental medicine

Witebsky E, Mohn JF.
PMID: 19871489
J Exp Med. 1945 Aug 01;82(2):143-56. doi: 10.1084/jem.82.2.143.

1. Rh substances are found in amniotic fluid. Not all anti-Rh sera seem to be suitable for the detection of Rh substances in amniotic fluid. Careful selection of Rh antisera, as well as quantitative considerations, determine success or failure...

Cite
Witebsky E, Mohn JF. INVESTIGATIONS ON THE OCCURRENCE OF Rh SUBSTANCES IN AMNIOTIC FLUID. J Exp Med. 1945;82(2):143-56doi: 10.1084/jem.82.2.143.
Witebsky, E., Mohn, J. F. (1945). INVESTIGATIONS ON THE OCCURRENCE OF Rh SUBSTANCES IN AMNIOTIC FLUID. The Journal of experimental medicine, 82(2), 143-56. https://doi.org/10.1084/jem.82.2.143
Witebsky, E, et al. "INVESTIGATIONS ON THE OCCURRENCE OF Rh SUBSTANCES IN AMNIOTIC FLUID." The Journal of experimental medicine vol. 82,2 (1945): 143-56. doi: https://doi.org/10.1084/jem.82.2.143
Witebsky E, Mohn JF. INVESTIGATIONS ON THE OCCURRENCE OF Rh SUBSTANCES IN AMNIOTIC FLUID. J Exp Med. 1945 Aug 01;82(2):143-56. doi: 10.1084/jem.82.2.143. PMID: 19871489; PMCID: PMC2135539.
Copy Download .nbib Format: NLM
PRODUCTION OF HEMORRHAGIC NECROTIC SKIN LESIONS IN THE RABBIT BY MEANS OF HEMOPHILUS INFLUENZAE AND HEMOPHILUS PERTUSSIS.

The Journal of experimental medicine

Witebsky E, Salm H.
PMID: 19870590
J Exp Med. 1937 Jan 01;65(1):43-57. doi: 10.1084/jem.65.1.43.

1. The intradermal injection of H. influenzae in the abdominal wall of rabbits induces inflammation, frequently combined with a central pustule. The corresponding injection of H. pertussis causes a bluish violet discoloration of the skin area involved which undergoes...

Cite
Witebsky E, Salm H. PRODUCTION OF HEMORRHAGIC NECROTIC SKIN LESIONS IN THE RABBIT BY MEANS OF HEMOPHILUS INFLUENZAE AND HEMOPHILUS PERTUSSIS. J Exp Med. 1937;65(1):43-57doi: 10.1084/jem.65.1.43.
Witebsky, E., & Salm, H. (1937). PRODUCTION OF HEMORRHAGIC NECROTIC SKIN LESIONS IN THE RABBIT BY MEANS OF HEMOPHILUS INFLUENZAE AND HEMOPHILUS PERTUSSIS. The Journal of experimental medicine, 65(1), 43-57. https://doi.org/10.1084/jem.65.1.43
Witebsky, E, and Salm, H. "PRODUCTION OF HEMORRHAGIC NECROTIC SKIN LESIONS IN THE RABBIT BY MEANS OF HEMOPHILUS INFLUENZAE AND HEMOPHILUS PERTUSSIS." The Journal of experimental medicine vol. 65,1 (1937): 43-57. doi: https://doi.org/10.1084/jem.65.1.43
Witebsky E, Salm H. PRODUCTION OF HEMORRHAGIC NECROTIC SKIN LESIONS IN THE RABBIT BY MEANS OF HEMOPHILUS INFLUENZAE AND HEMOPHILUS PERTUSSIS. J Exp Med. 1937 Jan 01;65(1):43-57. doi: 10.1084/jem.65.1.43. PMID: 19870590; PMCID: PMC2133470.
Copy Download .nbib Format: NLM
Response to experimental infection with mumps virus in rhesus monkeys.

Infection and immunity

Flanagan TD, Andrada JA, Barron AL, Witebsky E.
PMID: 16558030
Infect Immun. 1971 May;3(5):642-7. doi: 10.1128/iai.3.5.642-647.1971.

Experiments were conducted in which rhesus monkeys were infected with mumps virus by inoculation into the parotid gland. Virus was isolated from buccal swab specimens from animals up to 6 days after inoculation. Immunofluorescence staining for mumps antigen was...

Cite
Flanagan TD, Andrada JA, Barron AL, et al. Response to experimental infection with mumps virus in rhesus monkeys. Infect Immun. 1971;3(5):642-7doi: 10.1128/iai.3.5.642-647.1971.
Flanagan, T. D., Andrada, J. A., Barron, A. L., & Witebsky, E. (1971). Response to experimental infection with mumps virus in rhesus monkeys. Infection and immunity, 3(5), 642-7. https://doi.org/10.1128/iai.3.5.642-647.1971
Flanagan, T D, et al. "Response to experimental infection with mumps virus in rhesus monkeys." Infection and immunity vol. 3,5 (1971): 642-7. doi: https://doi.org/10.1128/iai.3.5.642-647.1971
Flanagan TD, Andrada JA, Barron AL, Witebsky E. Response to experimental infection with mumps virus in rhesus monkeys. Infect Immun. 1971 May;3(5):642-7. doi: 10.1128/iai.3.5.642-647.1971. PMID: 16558030; PMCID: PMC416210.
Copy Download .nbib Format: NLM
DISTRIBUTION OF BLOOD GROUP PROPERTIES AND BLOOD GROUP PROPERTY DESTROYING FACTORS IN THE INTESTINAL TRACT OF MAN.

The Journal of experimental medicine

Witebsky E, Neter E.
PMID: 19870436
J Exp Med. 1935 Sep 30;62(4):589-98. doi: 10.1084/jem.62.4.589.

1. The blood group specific substance A is present in the contents of the jejunum and upper ileum of persons belonging to Group A. 2. A marked decrease in the amount of A substance occurs in the lower ileum...

Cite
Witebsky E, Neter E. DISTRIBUTION OF BLOOD GROUP PROPERTIES AND BLOOD GROUP PROPERTY DESTROYING FACTORS IN THE INTESTINAL TRACT OF MAN. J Exp Med. 1935;62(4):589-98doi: 10.1084/jem.62.4.589.
Witebsky, E., & Neter, E. (1935). DISTRIBUTION OF BLOOD GROUP PROPERTIES AND BLOOD GROUP PROPERTY DESTROYING FACTORS IN THE INTESTINAL TRACT OF MAN. The Journal of experimental medicine, 62(4), 589-98. https://doi.org/10.1084/jem.62.4.589
Witebsky, E, and Neter, E. "DISTRIBUTION OF BLOOD GROUP PROPERTIES AND BLOOD GROUP PROPERTY DESTROYING FACTORS IN THE INTESTINAL TRACT OF MAN." The Journal of experimental medicine vol. 62,4 (1935): 589-98. doi: https://doi.org/10.1084/jem.62.4.589
Witebsky E, Neter E. DISTRIBUTION OF BLOOD GROUP PROPERTIES AND BLOOD GROUP PROPERTY DESTROYING FACTORS IN THE INTESTINAL TRACT OF MAN. J Exp Med. 1935 Sep 30;62(4):589-98. doi: 10.1084/jem.62.4.589. PMID: 19870436; PMCID: PMC2133296.
Copy Download .nbib Format: NLM
THE ISOLATION OF THE BLOOD GROUP SPECIFIC B SUBSTANCE.

The Journal of experimental medicine

Witebsky E, Klendshoj NC.
PMID: 19871051
J Exp Med. 1940 Nov 30;72(6):663-7. doi: 10.1084/jem.72.6.663.

The isolation of group specific B substance from human stomach juice is described. The substance is carbohydrate-like in nature and is as potent as the carbohydrate-like substance group A isolated from commercial pepsin and peptone respectively.

Cite
Witebsky E, Klendshoj NC. THE ISOLATION OF THE BLOOD GROUP SPECIFIC B SUBSTANCE. J Exp Med. 1940;72(6):663-7doi: 10.1084/jem.72.6.663.
Witebsky, E., & Klendshoj, N. C. (1940). THE ISOLATION OF THE BLOOD GROUP SPECIFIC B SUBSTANCE. The Journal of experimental medicine, 72(6), 663-7. https://doi.org/10.1084/jem.72.6.663
Witebsky, E, and Klendshoj, N C. "THE ISOLATION OF THE BLOOD GROUP SPECIFIC B SUBSTANCE." The Journal of experimental medicine vol. 72,6 (1940): 663-7. doi: https://doi.org/10.1084/jem.72.6.663
Witebsky E, Klendshoj NC. THE ISOLATION OF THE BLOOD GROUP SPECIFIC B SUBSTANCE. J Exp Med. 1940 Nov 30;72(6):663-7. doi: 10.1084/jem.72.6.663. PMID: 19871051; PMCID: PMC2135043.
Copy Download .nbib Format: NLM
PRIMARY SERUM TOXICITY AS DEMONSTRATED BY THE CHICKEN EMBRYO.

The Journal of experimental medicine

Witebsky E, Neter E.
PMID: 19870374
J Exp Med. 1935 Mar 31;61(4):489-99. doi: 10.1084/jem.61.4.489.

1. The 3 day old chicken embryo removed from its shell is a suitable test object for the demonstration of primary serum toxicity. Addition of normal rabbit type sera as well as Forssman antiserum causes the vascular network to...

Cite
Witebsky E, Neter E. PRIMARY SERUM TOXICITY AS DEMONSTRATED BY THE CHICKEN EMBRYO. J Exp Med. 1935;61(4):489-99doi: 10.1084/jem.61.4.489.
Witebsky, E., & Neter, E. (1935). PRIMARY SERUM TOXICITY AS DEMONSTRATED BY THE CHICKEN EMBRYO. The Journal of experimental medicine, 61(4), 489-99. https://doi.org/10.1084/jem.61.4.489
Witebsky, E, and Neter, E. "PRIMARY SERUM TOXICITY AS DEMONSTRATED BY THE CHICKEN EMBRYO." The Journal of experimental medicine vol. 61,4 (1935): 489-99. doi: https://doi.org/10.1084/jem.61.4.489
Witebsky E, Neter E. PRIMARY SERUM TOXICITY AS DEMONSTRATED BY THE CHICKEN EMBRYO. J Exp Med. 1935 Mar 31;61(4):489-99. doi: 10.1084/jem.61.4.489. PMID: 19870374; PMCID: PMC2133232.
Copy Download .nbib Format: NLM
A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2.

Journal of immunotherapy : official journal of the Society for Biological Therapy

Ohnmacht GA, Phan GQ, Mavroukakis SA, Steinberg SM, Shea YR, Witebsky FG, McIntyre LS, Goodwin RS, Muehlbauer PM, Morton KE, Rogers-Freezer LJ, Seipp CA, Rosenberg SA, Marincola FM.
PMID: 11449076
J Immunother (1991). 2001 Mar;24(2):188-192.

SUMMARY: Interleukin-2 (IL-2) has been used to treat patients with metastatic melanoma and renal cell cancer for nearly two decades, and much progress has been made in ameliorating its adverse effects. One bothersome adverse effect, oral pain or oral...

Cite
Ohnmacht GA, Phan GQ, Mavroukakis SA, et al. A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2. J Immunother (1991). 2001;24(2):188-192
Ohnmacht, G. A., Phan, G. Q., Mavroukakis, S. A., Steinberg, S. M., Shea, Y. R., Witebsky, F. G., McIntyre, L. S., Goodwin, R. S., Muehlbauer, P. M., Morton, K. E., Rogers-Freezer, L. J., Seipp, C. A., Rosenberg, S. A., & Marincola, F. M. (2001). A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2. Journal of immunotherapy : official journal of the Society for Biological Therapy, 24(2), 188-192.
Ohnmacht, Galen A., et al. "A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2." Journal of immunotherapy : official journal of the Society for Biological Therapy vol. 24,2 (2001): 188-192.
Ohnmacht GA, Phan GQ, Mavroukakis SA, Steinberg SM, Shea YR, Witebsky FG, McIntyre LS, Goodwin RS, Muehlbauer PM, Morton KE, Rogers-Freezer LJ, Seipp CA, Rosenberg SA, Marincola FM. A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2. J Immunother (1991). 2001 Mar;24(2):188-192. PMID: 11449076.
Copy Download .nbib Format: NLM
Fulminating Bacillus Coli Septicemia in Diabetic Women with Special Reference to the Clinical Diagnosis.

Transactions of the American Clinical and Climatological Association

Bowen BD, Witebsky E.
PMID: 21407602
Trans Am Clin Climatol Assoc. 1940;56:12-21.

No abstract available.

Cite
Bowen BD, Witebsky E. Fulminating Bacillus Coli Septicemia in Diabetic Women with Special Reference to the Clinical Diagnosis. Trans Am Clin Climatol Assoc. 1940;56:12-21
Bowen, B. D., & Witebsky, E. (1940). Fulminating Bacillus Coli Septicemia in Diabetic Women with Special Reference to the Clinical Diagnosis. Transactions of the American Clinical and Climatological Association, 5612-21.
Bowen, B D, and Witebsky, E. "Fulminating Bacillus Coli Septicemia in Diabetic Women with Special Reference to the Clinical Diagnosis." Transactions of the American Clinical and Climatological Association vol. 56 (1940): 12-21.
Bowen BD, Witebsky E. Fulminating Bacillus Coli Septicemia in Diabetic Women with Special Reference to the Clinical Diagnosis. Trans Am Clin Climatol Assoc. 1940;56:12-21. PMID: 21407602; PMCID: PMC2242196.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries